Results 1 to 10 of about 173,430 (355)

Soft Tissue Sarcomas

open access: yesCa-A Cancer Journal for Clinicians, 2004
Sarcomas are a heterogeneous group of rare tumors that arise predominantly from the embryonic mesoderm. They present most commonly as an asymptomatic mass originating in an extremity but can occur anywhere in the body, particularly the trunk, retroperitoneum, or the head and neck.
Janice N, Cormier, Raphael E, Pollock
exaly   +3 more sources

Bone and Soft Tissue Sarcoma [PDF]

open access: goldCancers, 2020
Bone and soft-tissue sarcomas are relatively rare tumors both in children and adults [...]
Antonio Ruggiero
openalex   +4 more sources

Avelumab use in Merkel cell carcinoma treatment

open access: yesNowotwory, 2022
Avelumab is a programmed death-ligand 1 (PD-L1) blocking human IgG1 lambda monoclonal antibody. It was the first immunotherapy to be approved for the treatment of MCC.
Monika Dudzisz-Śledź   +4 more
doaj   +1 more source

Definitive Radiotherapy in the Management of Non-Resectable or Residual Retroperitoneal Sarcomas: Institutional Cohort Analysis and Systematic Review

open access: yesCancer Control, 2021
Background: There is currently no consensus on optimal management of patients with primary or recurrent non-resectable/residual retroperitoneal sarcomas (RPS). The objective of this study was to document the outcomes of patients with primary or recurrent
Aleksandra Sobiborowicz   +3 more
doaj   +1 more source

Soft Tissue Sarcoma [PDF]

open access: yesJournal of the National Comprehensive Cancer Network, 2010
The soft-tissue sarcomas (STS) of childhood are a relatively rare and heterogeneous group of tumors that may occur anywhere in the body and respond quite differently to therapy. STSs account for 7.4% of all cancers in children younger than 20 years [1].
George D, Demetri   +23 more
openaire   +2 more sources

Soft tissue sarcomas [PDF]

open access: yesCurrent Problems in Surgery, 1996
Soft tissue sarcomas are relatively rare tumors with an annual incidence of 5000 to 6000 in the United States. The primary therapy is surgical resection with an adequate margin of normal tissue. For patients at high risk local control is improved with postoperative adjuvant radiation. Local recurrence rates vary depending on the anatomic site.
J J, Lewis, M F, Brennan
openaire   +4 more sources

Treatment of metastatic uveal melanoma

open access: yesNowotwory, 2022
Uveal melanoma is a rare malignancy with a poor prognosis. The risk of metastatic disease (mainly to the liver) exceeds 50% and is often observed many years after the primary treatment.
Mateusz M. Polaczek   +1 more
doaj   +1 more source

Will virtual multidisciplinary team meetings become the norm for musculoskeletal oncology care following the COVID-19 pandemic? - experience from a tertiary sarcoma centre

open access: yesBMC Musculoskeletal Disorders, 2021
Background Like with all cancers, multidisciplinary team (MDT) meetings are the norm in bone and soft tissue tumour (BST) management too. Problem in attendance of specialists due to geographical location is the one of the key barriers to effective ...
Raja Bhaskara Rajasekaran   +4 more
doaj   +1 more source

Postępowanie diagnostyczno-terapeutyczne u chorych na czerniaki oka — zalecenia eksperckie Polskiego Towarzystwa Onkologicznego

open access: yesNowotwory, 2022
< p > < /p >
Piotr Rutkowski   +7 more
doaj   +1 more source

Functional outcome of surgical treatment of adults with extremity osteosarcoma after megaprosthetic reconstruction—single-center experience

open access: yesJournal of Orthopaedic Surgery and Research, 2019
Background Osteosarcoma is the most common primary malignant bone tumor in adults and is usually located in the long bones. Standard treatment consists of perioperative chemotherapy and radical surgical resection.
Tomasz Goryń   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy